HSCS
NASDAQ HealthcareHeartSciences Inc. - Common Stock
Medical Devices
HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
๐ Market Data
| Price | $5.20 |
|---|---|
| Volume | 174,295 |
| Market Cap | 24.96M |
| RSI (14-Day) | 74.1 Overbought |
| 200-Day MA | $2.57 |
| 50-Day MA | $2.74 |
| 52-Week High | $5.21 |
| 52-Week Low | $1.63 |
| Forward P/E | -2.97 |
| Price / Book | 73.24 |
๐ฏ Investment Strategy Scores
HSCS scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Over-Hyped (97/100) โ this strategy Overbought stocks (potential short candidates).
Lowest fit among scored strategies: ๐ Moon Shot (1/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find HSCS in your text
Paste any article, transcript, or post โ the tool will extract HSCS and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-09-18.